.png){kind=small}
.png){kind=small}
BackTable / Urology / Podcast / Episode #219
GU ASCO Highlights: Key Takeaways for Clinicians
with Dr. Ben Maughan & Dr. Shilpa Gupta
Do you need a recap of the latest urologic oncology research presented at GU ASCO 2025? This episode of BackTable Urology features a multidisciplinary discussion among three leading voices in urology and medical oncology – Drs. Bogdana Schmidt, Shilpa Gupta, and Ben Maughan – covering the most notable results presented at this year’s meeting.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2025, March 11). Ep. 219 – GU ASCO Highlights: Key Takeaways for Clinicians [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Bogdana Schmidt
Dr. Bogdana Schmidt, MD, MPH, is a urologic surgeon specializing in urologic oncology at the University of Utah in Salt Lake City, Utah.
Dr. Shilpa Gupta
Dr. Shilpa Gupta is the director of Genitourinary Medical Oncology at Taussig Cancer Institute and co-leader of the Genitourinary Program at the Cleveland Clinic in Cleveland, Ohio.
Dr. Ben Maughan
Dr. Ben Maughan is a genitourinary oncologist at Huntsman Cancer Institute in Salt Lake City, Utah.
Synopsis
First, the doctors cover a wide range of topics including PARP inhibitors for prostate cancer, HER2-targeting antibody drug conjugates in bladder cancer, adjuvant chemotherapy for upper tract urothelial carcinoma, and biomarkers such as KIM-1 in kidney cancer. Highlighting the importance of multidisciplinary collaboration, the experts also critique the COSMIC-313 trial and discuss the nuances of applying new therapeutic combinations in real-world clinical practice.
Timestamps
00:00 - Introduction
09:20 - TALAPRO-2 Trial Insights
19:29 - Bladder Cancer: Immuno-Oncology Combinations and HER2
27:42 - NIAGARA and iNDUCT Trials
33:32 - Future Directions in Upper Tract Treatment
37:38 - Biomarkers in Kidney Cancer: KIM-1
46:43 - COSMIC-313: Triplet Therapy in Renal Cell Carcinoma
52:39 - Concluding Thoughts and Future Directions
Resources
Photocure:
https://www.photocure.com/
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
Articles
Topics
